Please login to the form below

Not currently logged in


This page shows the latest VTE news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s upadacitinib aces phase III trial

AbbVie’s upadacitinib aces phase III trial

Crucially for AbbvVie, there were no cases of venous thromboembolism (VTE) in the 1, 629-patent study, something that was observed in two earlier phase III studies of the drug ... Analysts said the lack of VTEs in the latest study reduced the risk in the

Latest news

More from news
Approximately 3 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • Modern anticoagulants threaten status quo Modern anticoagulants threaten status quo

    It is indicated for the prevention of VTE after orthopaedic surgery and is administered subcutaneously once daily. ... The drug is also in phase III development for the acute treatment of VTE.

  • Case study: Using avatar technology to reduce VTE

    The programme was endorsed by The Royal Pharmaceutical Society and promoted among VTE Exemplar Centres. ... Evidence from the field suggests pharmacists have been encouraged to pick up the gauntlet of VTE prevention.

  • Go with the flow

    risk. VTE risk assessment has been included as a DH priority in the NHS Operating Framework 2010/11.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • NOAC Education: Empowering Stroke Prevention

    Prophylactic anticoagulation is also being explored in conditions such as embolic strokes of undetermined source (ESUS) or when there is a risk of a patient developing venous thromboembolism (VTE).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....